Gene: CIROP
Official Full Name: ciliated left-right organizer metallopeptidaseprovided by HGNC
Gene Summary: Predicted to enable peptidase activity. Predicted to be involved in establishment of left/right asymmetry. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18689 | CIROP Knockout cell line (HEK293) | Human | CIROP | 1:3~1:6 | Negative | Online Inquiry |
CIROP Gene Knockout Cell Lines are specifically engineered cellular models that allow for the systematic investigation of gene function through targeted gene disruption. These cell lines utilize advanced CRISPR-Cas9 technology to introduce precise deletions within specific genomic loci, facilitating the study of gene essentiality, cellular pathways, and gene interactions in various biological contexts.
The primary mechanism behind CIROP Gene Knockout Cell Lines involves the CRISPR-Cas9 system, which employs guide RNAs to direct the Cas9 nuclease to a designated gene, leading to double-strand breaks. These breaks are subsequently repaired by the cell’s non-homologous end joining pathway, resulting in insertions or deletions (indels) that disrupt gene function. This targeted approach provides researchers with robust models to study the phenotypic consequences of gene loss, enabling insights into gene regulation, disease mechanisms, and potential therapeutic targets.
In the realm of scientific research and clinical applications, CIROP Gene Knockout Cell Lines are invaluable for investigating genetic disorders, cancer biology, and drug resistance phenomena. Their ability to model gene function in relevant cellular contexts enhances the translational potential of experimental results, making them essential tools for both academic and industrial laboratories.
What sets CIROP Gene Knockout Cell Lines apart from conventional knockout models is their rigorously validated performance and compatibility with high-throughput screening methods. They provide researchers with high specificity, efficiency, and reproducibility of gene disruption, significantly accelerating discovery timelines compared to traditional methods such as transgenic animals.
For researchers, clinicians, and pharmaceutical developers, the ability to work with accurate gene knockout models can lead to breakthroughs in understanding complex biological systems and developing innovative treatments. Leveraging our company’s expertise in genetic engineering and cell line development, we are committed to providing top-tier biological products that empower scientific innovation and address unmet medical needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.